Albany, NY, United States of America

Sol J Daum


Average Co-Inventor Count = 2.5

ph-index = 8

Forward Citations = 144(Granted Patents)


Company Filing History:


Years Active: 1976-1999

Loading Chart...
25 patents (USPTO):Explore Patents

Sure, I can help with that! Here is the article about inventor Sol J Daum:

Title: The Innovative Journey of Sol J Daum

Introduction:

In the realm of patents and pharmaceutical innovations, Sol J Daum stands tall as an inventive mind hailing from Albany, NY. With 25 patents to his name, Daum has made significant contributions to the field of pharmaceuticals and x-ray technologies.

Latest Patents:

Sol J Daum's recent patents include groundbreaking inventions such as 6-substituted pyrazolo[3,4-d]pyrimidin-4-ones and compositions. These inventions are aimed at c-GMP-phosphodiesterase inhibition, offering novel methods for treating heart failure and hypertension. Additionally, Daum has patented 2,4,6-triiodo-5-substituted-amino-isophthalate esters, which have proven to be valuable in x-ray technologies.

Career Highlights:

Throughout his career, Sol J Daum has showcased his expertise while working at renowned companies like Sterling Drug Inc. and Sterling Winthrop Inc. His innovative spirit and dedication to research have led to the development of impactful pharmaceutical compositions and x-ray compounds.

Collaborations:

Daum's success in the world of inventions would not have been possible without the collaboration of talented individuals. Notable coworkers such as Robert L Clarke and Edward R Bacon have contributed to the realization of his innovative ideas, further solidifying Daum's position as a respected inventor.

Conclusion:

In conclusion, Sol J Daum's journey as an inventor has been marked by a series of groundbreaking patents and collaborations that have shaped the landscape of pharmaceuticals and x-ray technologies. His dedication to innovation serves as an inspiration for aspiring inventors and underscores the importance of relentless pursuit of new solutions to complex challenges in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…